- Home
- INO vs AEI Comparison
INO vs AEI Comparison
Compare INO & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- AEI
- Stock Information
- Founded
- INO 1979
- AEI 2014
- Country
- INO United States
- AEI United States
- Employees
- INO N/A
- AEI N/A
- Industry
- INO Medical/Dental Instruments
- AEI Building operators
- Sector
- INO Health Care
- AEI Real Estate
- Exchange
- INO Nasdaq
- AEI Nasdaq
- Market Cap
- INO 136.6M
- AEI 124.7M
- IPO Year
- INO 1998
- AEI N/A
- Fundamental
- Price
- INO $2.58
- AEI $3.21
- Analyst Decision
- INO Buy
- AEI
- Analyst Count
- INO 5
- AEI 0
- Target Price
- INO $8.80
- AEI N/A
- AVG Volume (30 Days)
- INO 1.0M
- AEI 85.6K
- Earning Date
- INO 11-10-2025
- AEI 11-13-2025
- Dividend Yield
- INO N/A
- AEI N/A
- EPS Growth
- INO N/A
- AEI N/A
- EPS
- INO N/A
- AEI N/A
- Revenue
- INO $182,337.00
- AEI $16,069,911.00
- Revenue This Year
- INO N/A
- AEI N/A
- Revenue Next Year
- INO $14,751.49
- AEI N/A
- P/E Ratio
- INO N/A
- AEI N/A
- Revenue Growth
- INO N/A
- AEI 74.28
- 52 Week Low
- INO $1.30
- AEI $0.70
- 52 Week High
- INO $5.80
- AEI $4.55
- Technical
- Relative Strength Index (RSI)
- INO 58.30
- AEI 62.77
- Support Level
- INO $2.21
- AEI $2.35
- Resistance Level
- INO $2.49
- AEI $2.61
- Average True Range (ATR)
- INO 0.14
- AEI 0.27
- MACD
- INO -0.01
- AEI 0.03
- Stochastic Oscillator
- INO 81.29
- AEI 66.65
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.